PODCAST · news
Onpode
by Onpode
Short, made-for-you episodes on the topics, people, and companies shaping the world — researched, fact-checked, and refreshed daily. Follow any topic and get your own feed at onpode.com.
-
50
The scaling paradox: how larger models develop unexpected emergent abilities
Large neural networks display emergent abilities — capabilities such as reasoning, code generation, abstract thinking, and in-context learning that are absent or near-random in smaller models but appear suddenly and reliably once scale in parameters, data, and compute crosses certain thresholds. The term "emergent abilities" gained traction through research by Jason Wei et al.
-
49
Insilico Medicine's AI-designed drug is showing early signs it can slow aging—a real-world biotech application
Insilico Medicine, a clinical-stage biotechnology company founded by Alex Zhavoronkov, has published two landmark studies on its AI-designed drug candidate rentosertib (also referred to as INS018_055 or ISM001-055), developed to treat idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung-scarring disease.
-
48
Mistral's €3B funding round highlights Europe racing to compete with US AI giants amid a global talent war
On 8 September 2026, Paris-based AI startup Mistral AI announced the close of a €3 billion Series D funding round, which the company described as the largest equity fundraising ever completed by a privately held European technology company.
-
47
OpenAI claims it solved a 90-year-old physics problem—but analysts say it signals a real shift from demos to science
On September 8, 2026, OpenAI published a claimed solution to the Navier–Stokes existence and smoothness problem, one of seven Millennium Prize Problems established by the Clay Mathematics Institute in 2000, each carrying a $1 million award.
-
46
Meta just rolled out Muse, an AI agent that autonomously sends emails and books travel
On September 8, 2026, Meta launched Muse, a personal AI agent designed to autonomously execute real-world tasks on behalf of users rather than simply answer questions. Muse is available in the United States via a dedicated iOS and Android app, a web interface at Muse.ai, and through WhatsApp direct messaging; Meta has indicated it will also be accessible through its AI smart glasses "soon."
-
45
Why the attention mechanism lets models train faster and deeper than previous architectures
The transformer architecture, introduced in the 2017 paper "Attention Is All You Need," replaced recurrent neural networks (RNNs) with a self-attention mechanism that allows every token in a sequence to directly compare itself with every other token in a single layer.
-
44
China's export growth hit record levels in August, driven by surging demand for high-tech and AI-related products amid weak domestic demand
China's exports surged 25% year-on-year in August 2026 in U.S. dollar terms, accelerating from 23.9% growth in July and matching market forecasts, according to customs data released on September 8, 2026.
-
43
French startup Mistral just raised €3 billion at a €21 billion valuation—the biggest round by a private European tech firm, backed by Samsung and PSG Equity
On September 8, 2026, Paris-based Mistral AI announced the close of a €3 billion Series D funding round at a post-money valuation of more than €21 billion (approximately $24 billion), which the company described as the largest equity funding round ever completed by a privately owned European technology company.
-
42
AI agents can now formalize theorem proofs and run businesses — but OpenAI warns monitoring their reasoning is hitting hard limits
In a development dated to approximately September 2026, Anthropic's Claude agents reportedly formalized Fermat's Last Theorem in the Lean proof assistant after roughly 11 days of largely autonomous work.
-
41
Arm just unveiled a new AI-native compute platform built specifically for agentic AI and mobile graphics
On September 8, 2026, Arm announced CSS for Mobile 2, a compute platform it describes as AI-native, designed to support agentic AI workloads and advanced mobile graphics within smartphone power and thermal constraints.
-
40
Why teams can't have star depth — the salary cap ceiling explains roster constraints
Salary caps and equivalent financial regulations in major professional sports leagues impose a binding ceiling on total team payroll, creating a structural zero-sum constraint in roster construction.
-
39
The resource curse: why oil-rich states often have weaker institutions than resource-poor neighbors
The "resource curse" — also called the "paradox of plenty" or "poverty paradox" — is a widely studied hypothesis in political economy holding that countries with abundant extractable natural resources (oil, gas, minerals, diamonds) tend to exhibit slower economic growth, weaker democratic institutions, higher corruption, and poorer development outcomes than resource-scarce counterparts.
-
38
How a blacklisted Chinese tech giant kept buying Nvidia's best AI chips despite US sanctions
A New York Times investigation published September 6, 2026, revealed that Inspur Group — a Chinese technology company blacklisted by the U.S. in 2023 for its work with the Chinese military — continued acquiring Nvidia's most advanced AI chips through its Silicon Valley subsidiary, Aivres Systems Inc.
-
37
The NBA just hammered the Clippers — now they must extend their longest winning streak while crippled
On September 2, 2026, the NBA announced sweeping punishments against the Los Angeles Clippers following an approximately 11-month investigation into salary-cap circumvention.
-
36
Von der Leyen is in Greenland right now, strengthening EU control over Arctic resources
European Commission President Ursula von der Leyen arrived in Nuuk, Greenland on Sunday, September 6, 2026, for a two-day visit concluding September 7. The visit is explicitly framed as a show of political solidarity with Greenland and Denmark in the face of ongoing US President Donald Trump's rhetoric about annexing the world's largest island.
-
35
Novartis pelacarsen lowered Lp(a) levels in 8,323 patients—but didn't reduce cardiovascular events
On September 4, 2026, Novartis and its partner Ionis Pharmaceuticals announced topline results from the Lp(a)HORIZON Phase 3 cardiovascular outcomes trial (NCT04023552).
-
34
China just cracked seawater uranium extraction—8 times better than US methods
Chinese researchers at the Qingdao Institute of Bioenergy and Bioprocess Technology, part of the Chinese Academy of Sciences (CAS), have announced a novel material called PhosCage designed to extract dissolved uranium from seawater. PhosCage is described as a sponge-like, phosphate-based molecular structure ("chemical trap") that binds selectively to uranium ions.
-
33
New screening advances target the 1-in-8 lifetime risk of prostate cancer diagnosis
Prostate cancer is the most common solid organ cancer in men and the fifth leading cause of cancer-related deaths globally. Epidemiologic data consistently place a man's lifetime diagnosis risk at approximately 1 in 8. The American Cancer Society projects 333,830 new U.S.
-
32
As Trump demands Greenland, the EU is racing to invest and bind it closer
European Commission President Ursula von der Leyen arrived in Greenland on Sunday, September 6, 2026, for a two-day visit to the Danish autonomous territory. The trip is a high-profile diplomatic signal of EU solidarity with Greenland and Denmark amid repeated public statements by US President Donald Trump asserting that Greenland "should be controlled by the United States, not by Denmark."
-
31
Bill Ackman's daughter regained sight using first-of-its-kind cell transfer from her own leg
In February 2026, Lucy Ackman, the 26-year-old daughter of billionaire hedge fund manager Bill Ackman, collapsed in her Brooklyn apartment after suffering a catastrophic brain hemorrhage that left her unable to move, speak, or see. Conventional treatments could not reverse the damage to her optic pathways, and her prognosis for visual recovery was described as extremely poor.
-
30
FDA just cleared three breakthrough drugs—for rare neurological disease, ADHD, and breast cancer
In early September 2026, the U.S. Food and Drug Administration approved three distinct therapies, each representing a regulatory or scientific first in its category. On September 3, 2026, the FDA approved Zanvastro (zilganersen), developed by Ionis Pharmaceuticals, for Alexander disease (AxD) in both pediatric and adult patients.
-
29
Why randomized trials work — the statistical mechanism that isolates cause
Randomized controlled trials (RCTs) are a methodological approach designed to establish causal relationships between interventions and outcomes by randomly assigning participants to treatment and control groups.
-
28
Why journals reward novelty over replication — the structural mechanism
Scientific publishing operates under a structural bias toward novel, positive, and surprising results. Journals compete on readership, citations, and prestige, creating a reward system that favors findings that generate new headlines or high citation bursts over those that are merely accurate or confirmatory.
-
27
As we elevate AI capabilities, we're learning to think less of our fellow humans, warns Atlantic essay
David Brooks, writing in The Atlantic, has published at least two relevant pieces bearing on the tension between AI capability and human dignity. His June 2026 essay "The People Who Will Thrive in the AI Age" argued that success in the AI era depends not on raw intelligence but on one's willingness to wrestle with difficult problems rather than outsource thinking to machines.
-
26
AI solved protein folding, but proteins keep changing their minds
AlphaFold, developed by DeepMind and publicly led by Demis Hassabis and John Jumper, transformed structural biology by predicting three-dimensional protein structures from amino acid sequences with unprecedented accuracy.
-
25
Why sharing uncertainty and struggle makes speakers more trustworthy, not less
Personal narratives that incorporate failure, doubt, or revision tend to build listener trust through a mechanism researchers call "narrative credibility" — a quality distinct from factual accuracy alone. When speakers recount lived experience rather than deliver polished talking points, audiences read sensory detail, plausibility, internal consistency, and candor as credibility cues.
-
24
Why oil priced in dollars gives the US structural asymmetry in global finance
The petrodollar system describes the structural arrangement by which globally traded oil is priced and settled in U.S. dollars, creating persistent transactional and reserve demand for U.S. currency and Treasury debt.
-
23
First US strike on Iranian forces in a month heightens escalation risk and tests US grip on Strait of Hormuz
On August 30, 2026, U.S. Central Command (CENTCOM) struck two Islamic Revolutionary Guard Corps (IRGC) rocket launchers on Larak Island in the Strait of Hormuz. According to U.S. officials, IRGC personnel had been observed preparing to launch rockets capable of deploying sea mines into the waterway. CENTCOM commander Admiral Brad Cooper had previously stated that U.S.
-
22
Moscow and Beijing's SCO summit shows how sanctions and proxy conflicts are binding them closer on energy and defense
In May 2026, Russian President Vladimir Putin and Chinese President Xi Jinping met in Beijing, signing over 20 bilateral cooperation documents and issuing joint statements that described their relationship as a "comprehensive strategic partnership of coordination for a new era."
-
21
While conflict rages, Putin and the Iranian president coordinate with Beijing and New Delhi at SCO summit
The Shanghai Cooperation Organization (SCO) held its 25th-anniversary summit in Bishkek, Kyrgyzstan on August 31–September 1, 2026.
-
20
Xi, Modi, and Putin just met in Kyrgyzstan to counter U.S. influence and promote a multipolar world
The 26th Meeting of the Council of Heads of State of the Shanghai Cooperation Organization (SCO) convened in Bishkek, Kyrgyzstan, from August 31 to September 1, 2026. The summit marked the SCO's 25th anniversary and closed Kyrgyzstan's 2025–2026 rotating chairmanship under the theme "25 Years of the SCO: Together for Sustainable Peace, Development and Prosperity."
-
19
How breakout seasons return to baseline — the mechanism behind regression to the mean
Regression toward the mean is a statistical phenomenon in which extreme observations — unusually high or low performances — tend to be followed by results closer to a long-run average. In sports, this manifests when a player who posts an exceptional single season (a career-high batting average, an outlier shooting percentage, or a record win total) performs more modestly the following year.
-
18
Álvarez to Arsenal, Gakpo to Manchester City, Enzo moves dominate as window closes
As the Premier League's summer 2026 transfer window approached its September 1 deadline (23:00 BST), three interconnected storylines dominated discussion: Julián Álvarez potentially moving to Arsenal, Cody Gakpo moving from Liverpool to Manchester City, and Enzo Fernández moving from Chelsea to Manchester City.
-
17
MarShawn Lloyd's unproven track record clashes with his rising fantasy draft position
MarShawn Lloyd, a third-round pick by the Green Bay Packers in the 2024 NFL Draft out of USC, enters the 2026 season with a sharply rising fantasy ADP despite an extremely thin professional production record.
-
16
Can the Knicks extend Miles McBride and other key starters with limited cap room?
The New York Knicks, as reigning NBA champions, enter the 2026-27 season navigating a series of interconnected roster and contract decisions shaped by tight salary cap constraints. The most prominently discussed player is Miles "Deuce" McBride, a guard currently on a three-year, $13 million extension signed in December 2023, with a 2026-27 salary of approximately $3.96 million.
-
15
Timberwolves waive Konchar, trade Green to Jazz as NBA teams lock in preseason rosters
On August 29, 2026, the Minnesota Timberwolves executed a trade with the Utah Jazz, sending guard Josh Green and cash considerations to Utah in exchange for forwards Cody Williams and John Konchar. The deal was first reported by ESPN's Shams Charania and officially confirmed by the Timberwolves via press release.
-
14
How randomization breaks the causation-correlation problem in medical evidence
Randomized controlled trials (RCTs) are widely regarded as the methodological gold standard for establishing causal relationships between interventions and outcomes in medicine. The core mechanism is random assignment: by allocating participants to treatment or control groups via chance, RCTs break the link between confounders — both known and unknown — and the treatment received.
-
13
Why medicine excels at antibiotics but struggles with obesity and diabetes
Modern medicine has achieved dramatically different outcomes when confronting acute infectious diseases versus chronic metabolic diseases, and the structural reasons for this disparity are increasingly well understood.
-
12
Before germ theory, medicine was intuition — how Pasteur and Koch changed everything
The germ theory of disease, which holds that specific microorganisms cause specific illnesses, emerged in the mid-19th century and displaced centuries-old frameworks including miasma theory (attributing disease to "bad air" from decaying matter) and humoral theory (attributing illness to imbalances in bodily fluids).
-
11
The structural economics of treatment vs prevention — why cures fund research better than prevention does
Healthcare systems and pharmaceutical markets exhibit a persistent structural imbalance: preventive interventions—vaccines, tobacco cessation, blood-pressure screening, early cancer detection, and lifestyle programs—are generally more cost-effective than treatment for established disease, yet funding and innovation incentives disproportionately flow toward treatment.
-
10
Why placebos trigger real physiological changes — the neurobiology of expectation
Placebos — inert substances or sham procedures — produce measurable physiological changes when a patient expects benefit. Contemporary neuroscience frames the placebo effect not as a psychological illusion but as a genuine psychobiological phenomenon engaging specific neural and endocrine systems.
-
9
Growing consensus among physicists: quantum mechanics is deterministic, not random—challenging core assumptions about free will
The question of whether quantum events are fundamentally random or governed by deterministic hidden rules is one of the oldest unresolved debates in physics, with direct implications for concepts of fate, free will, and the nature of reality.
-
8
NASA weaponized old spy satellites to peer deeper into the universe than ever before
The Nancy Grace Roman Space Telescope — NASA's next flagship space observatory — is built around a 2.4-meter primary mirror transferred to NASA by the National Reconnaissance Office (NRO) in 2012. That mirror originated from declassified U.S. spy-satellite optics, part of hardware that had been developed under classified reconnaissance programs and later deemed surplus to intelligence needs.
-
7
A 252-million-year extinction is repeating now: warming oceans losing oxygen, marine life suffocating
A 2026 study published in the Proceedings of the National Academy of Sciences (PNAS), led by J. Andres Marquez and including Stanford University's Erik A. Sperling, provides direct physiological evidence linking the end-Permian mass extinction (~252 million years ago) to temperature-dependent hypoxia—the combined lethal effect of ocean warming and deoxygenation.
-
6
Scientists just debunked a 70-year-old neuroscience myth about how your brain works
The popular notion that human decision-making is governed by a battle between an ancient "lizard brain" and a rational cortex—known as the triune brain hypothesis—is now broadly rejected by neuroscience.
-
5
The power law: how a handful of hundred-million-dollar exits generate most VC fund returns
Venture capital returns follow a power law distribution, meaning a disproportionately small fraction of portfolio investments generate the vast majority of a fund's total returns. Empirical evidence suggests that roughly 5–15% of investments in a typical fund account for most of its gains, while approximately 75% of venture-backed companies never return cash to investors.
-
4
First-ever Caltech math hackathon for startups offers $1M+ compute to 100 teams
Sathvik Redrouthu, a mathematics student at the California Institute of Technology (Caltech) and formerly associated with startups Instachip (Y Combinator-backed) and Procyon Photonics, as well as the AI chip company Etched, has organized the "Caltech Mathathon" — described as the first hackathon exclusively dedicated to research-level mathematics.
-
3
Garry Tan: startups must reorganize around AI agents that scale tiny teams now
In an August 2026 appearance on the a16z podcast, Y Combinator CEO Garry Tan articulated a concrete framework for how early-stage startups can use AI agents to replace traditional headcount scaling.
-
2
The structural reasons home teams win more — and why video review hasn't eliminated the gap
Home-field advantage is a well-documented, cross-sport phenomenon in which home teams win at rates consistently above 50%. Aggregated studies place typical winning percentages for home teams between just above 50% and as high as 70%, varying by sport and era.
-
1
Why building a championship roster requires choosing between proven stars and salary flexibility
In salary-capped professional sports, teams face a fundamental structural tradeoff: committing large, long-term contracts to star players locks in substantial portions of a fixed payroll ceiling, reducing flexibility to address roster weaknesses, sign depth players, or absorb injuries.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Short, made-for-you episodes on the topics, people, and companies shaping the world — researched, fact-checked, and refreshed daily. Follow any topic and get your own feed at onpode.com.
HOSTED BY
Onpode
CATEGORIES
Loading similar podcasts...